Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 0 results

Not applicableLooking for participantsNCT07786493
What this trial is testing

HDR Endorectal Brachytherapy With 3D-Printed Guidance and Local Shielding for Rectal Cancer Organ Preservation

Who this might be right for
Rectal Cancer, Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital 50
Large-scale testing (Phase 3)Ended earlyNCT03862170
What this trial is testing

Antibiotic Prophylaxis for HDR Brachytherapy in the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer
CR-CSSS Champlain-Charles-Le Moyne 158
Testing effectiveness (Phase 2)Study completedNCT02628041
What this trial is testing

HDR Brachytherapy vs. LDR Brachytherapy Monotherapy in Localized Prostate Cancer

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 30
Not applicableLooking for participantsNCT05786742
What this trial is testing

Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.

Who this might be right for
Prostate CancerRadiotherapy Side EffectHypofractionation+3 more
CHU de Quebec-Universite Laval 205
Large-scale testing (Phase 3)UnknownNCT01839994
What this trial is testing

Conformal Radiotherapy (CRT) Alone Versus CRT Combined With HDR BT or Stereotactic Body Radiotherapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Maria Sklodowska-Curie National Research Institute of Oncology 350
Not applicableStudy completedNCT02618161
What this trial is testing

Timing of HDR With EBRT in Localised Prostate Cancer,Toxicity and Quality of Life Assessment

Who this might be right for
Prostate Cancer
Mid and South Essex NHS Foundation Trust 100
Testing effectiveness (Phase 2)Ended earlyNCT03553602
What this trial is testing

HDR Brachytherapy, EBRT and STAD for the Treatment of Prostate Cancer

Who this might be right for
Prostate Cancer - Recurrent
Loyola University 3
Large-scale testing (Phase 3)Active Not RecruitingNCT02303327
What this trial is testing

Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients

Who this might be right for
Prostate Cancer
Sir Mortimer B. Davis - Jewish General Hospital 307
Large-scale testing (Phase 3)Active Not RecruitingNCT04497844
What this trial is testing

Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for the Treatment of Participants With Deleterious Germline or Somatic Homologous Recombination Repair (HRR) Gene-MutatedProstatic Neoplasms (mCSPC)

Who this might be right for
Prostatic Neoplasms
Janssen Research & Development, LLC 696